Ironwood Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
464,902
+85,202
+22% +$2.15M 1.81% 12
2026
Q1
$9.6M Buy
379,700
+23,778
+7% +$607K 1.68% 14
2025
Q4
$9.08M Buy
355,922
+48,805
+16% +$1.25M 1.54% 17
2025
Q3
$7.87M Buy
307,117
+282,707
+1,158% +$7.17M 1.39% 20
2025
Q2
$610K Hold
24,410
0.13% 99
2025
Q1
$610K Buy
+24,410
New +$604K 0.13% 99

Other funds holding IBDX

Ironwood Financial's IBDX Position: Q2 2026 in Review

Ironwood Financial increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 22% in Q2 2026, buying an estimated $2.15M and bringing the position to 464,902 shares worth $11.6M. The position accounts for 1.81% of the portfolio, ranked #12.

Ironwood Financial first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Ironwood Financial held 464,902 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $11.6M as of Q2 2026.
  • Ironwood Financial bought 85,202 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.15M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.81% of Ironwood Financial's portfolio in Q2 2026, its #12 holding.
  • Ironwood Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Ironwood Financial's 13F filing for Q2 2026, filed 17 Jul 2026.